Back
Brainstorm Cell Therapeutics Quote, Financials, Valuation and Earnings
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
15
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.38
Seasonality Move:
13.57%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.Brainstorm Cell Therapeutics Price Quote
$0.38
Brainstorm Cell Therapeutics Key Stats
Sell
15
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Day range:
$0.37 - $0.43
52-week range:
$0.13 - $3.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
539.4K
Avg. volume:
1.2M
1-year change:
-87.66%
Market cap:
$26M
Revenue:
$0
EPS:
$-0.41
How Much Does Brainstorm Cell Therapeutics Make?
Data Unavailable
Is Brainstorm Cell Therapeutics Growing As A Company?
Data Unavailable
Brainstorm Cell Therapeutics Stock Price Performance
-
Did Brainstorm Cell Therapeutics Stock Go Up Last Month?
Brainstorm Cell Therapeutics share price went down by -44.87% last month -
Did BCLI's Share Price Rise Over The Last Year?
BCLI share price fell by -87.66% over the past 1 year
What Is Brainstorm Cell Therapeutics 52-Week High & Low?
-
What Is Brainstorm Cell Therapeutics’s 52-Week High Share Price?
Brainstorm Cell Therapeutics has traded as high as $3.34 over the past 52 weeks -
What Is Brainstorm Cell Therapeutics’s 52-Week Low Share Price?
Brainstorm Cell Therapeutics has traded as low as $0.13 over the past 52 weeks
Brainstorm Cell Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Brainstorm Cell Therapeutics?
-
How Much Debt Does Brainstorm Cell Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Brainstorm Cell Therapeutics Have?
Cash and short term investments quarterly total is $1.3M -
What Is Brainstorm Cell Therapeutics’s Book Value Per Share?
Book value per share is -0.08
Is Brainstorm Cell Therapeutics Cash Flow Positive?
-
What Is BCLI Cash Flow From Operations?
Cash flow from operations (TTM) is -$20.5M -
What Is Brainstorm Cell Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19M -
What Is Brainstorm Cell Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $2.2M
Brainstorm Cell Therapeutics Return On Invested Capital
Data Unavailable
Brainstorm Cell Therapeutics Earnings Date & Stock Price
-
What Is Brainstorm Cell Therapeutics's Stock Price Today?
A single share of BCLI can be purchased today for 0.38 -
What Is Brainstorm Cell Therapeutics’s Stock Symbol?
Brainstorm Cell Therapeutics trades on the nasdaq under the ticker symbol: BCLI -
When Is Brainstorm Cell Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Brainstorm Cell Therapeutics is scheduled on May 15, 2024 -
When Is BCLI's next ex-dividend date?
Brainstorm Cell Therapeutics's next ex-dividend date is May 4, 2024 -
How To Buy Brainstorm Cell Therapeutics Stock?
You can buy Brainstorm Cell Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Brainstorm Cell Therapeutics Competitors
-
Who Are Brainstorm Cell Therapeutics's Competitors?
Below is a list of companies who compete with Brainstorm Cell Therapeutics or are related in some way:
Brainstorm Cell Therapeutics Dividend Yield
Data Unavailable
Brainstorm Cell Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.09% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 2.50 |
| Upside from Last Price: | 557.89% |